AzTrials
AzTrials

Neonatal SepsisPhase 2NCT06002295

A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns

A Phase 2 study testing Chlorhexidine Topical Cream and Methylated Spirit in people with Neonatal Sepsis and Omphalitis, run by Sheikh Zayed Federal Postgraduate Medical Institute at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Introduction: Neonatal sepsis in one of the leading cause of death in developing countries. Umbilical cord care is important as it may lead to infection. Topical treatment can help to reduce the chances of infection as well as increase the chances of early removal. Read more about this study

Who is it for?
Ages 1 day to 10 daysHealthy volunteers can take part
Conditions the study is for
Neonatal Sepsis, Omphalitis
What is being tested?
Chlorhexidine Topical Cream and Methylated Spirit
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 sitePakistan
Study dates
12 Sep 2020to 19 Nov 2021
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 10 days
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Term neonates of either gender born via cesarean section or spontaneous vaginal delivery at Shaikh Zayed Hospital after taking informed consent of parents.
  • Antiseptic agent started from 1st day of life \& up to 10 days continued without missing dose

Who cannot join

  • Newborns with congenital defects or cord anomalies.
  • Laboratory or clinical evidence of sepsis.
  • Preterm newborns
  • Newborns having very low birth weight <1.5 kg
  • Any evidence of asphyxia during birth.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Sheikh Zayed Federal Postgraduate Medical Institute

    Lahore, Punjab Province, 54500

Other trials in Pakistan

About this study

Introduction: Neonatal sepsis in one of the leading cause of death in developing countries. Umbilical cord care is important as it may lead to infection. Topical treatment can help to reduce the chances of infection as well as increase the chances of early removal. In this regard methylated spirit and chlorhexidine are found to be effective.

Aims and Objectives: To compare the effectiveness of 4% chlorhexidine and methylated spirit in newborns for prevention of omphalitis and neonatal sepsis.

Materials and Methods: This randomized control trial was carried out in neonatal unit of Shaikh Zayed Hospital Lahore. After meeting the inclusion criteria, 300 neonates were enrolled. In group A 4% chlorhexidine was applied for cord care and in group B methylated spirit was used. Neonates were followed till 10th day of life. Careful examination was done for cord separation and for any signs of omphalitis or sepsis. If the neonate had no signs and symptoms of omphalitis and sepsis on 10th day of follow up then it was treatment success.

Read the detailed description

Introduction:

Neonatal sepsis in one of the leading causes of death in neonates in developing countries. Infection of the umbilical cord often leads to infection in the blood. World Health Organization (WHO) recommends 4% chlorhexidine to prevent omphalitis and neonatal sepsis. In Pakistan the investigators use methylated spirit for prophylaxis of omphalitis as 4% chlorhexidine is not available and expensive to use. Some commercial gels containing 2% chlorhexidine is available, but these are not as effective as methylated spirit.

Chlorhexidine gel is an antiseptic agent with broad-spectrum bactericidal and bacteriostatic properties effective against gram-negative bacteria and fungi with rapid pathogen killing rates. Methylated spirit on the other hand is both bactericidal, mycobactericidal, fungicidal, and viricidal agent.

In Pakistan Staphylococcal aureus is common pathogen in umbilical discharge. Some low cost prevention therapy should be used. Methylated spirit is commonly used for cord care. A study was conducted to explore about cord care practices in African setting which showed that 73.2% respondents consider methylated spirit as most important agent for cord care.

Chlorhexidine is available in different concentrations for antiseptic purpose. Efficacy of all concentrations is comparable but 4% chlorhexidine concentration is more effective in inhibiting organism's flora as compared to 2% chlorhexidine. Since then, multiple studies were done to compare between methylated spirit and 4% chlorhexidine. Methylated spirit is equally safe where 4% chlorhexidine is unavailable.

In Pakistan 57% deaths occur in neonatal period. Pakistan has highest neonatal mortality rate of 42 per 1000 live births. In developing countries neonatal sepsis is aggravated by home deliveries, antibiotic resistance and less medical staff. The most important way to decrease mortality and morbidity due to infections is prevention at an early stage. According to a study conducted in Karachi, omphalitis is 217.4/1000 live births from which moderate-severe omphalitis is 170/1000 live births and associated with sepsis is 20.4/1000 live births. Various antiseptics used in neonatal intensive care units include chlorhexidine, alcohol, iodine, hexachlorophene \& octenidine. Each agent having its own advantages and adverse effects. However best antiseptic is yet to be determined.

World Health Organization (WHO) recommends application for 4 percent chlorhexidine in high neonatal mortality area and methylated spirit for cord care while methylated spirit is commonly used agent for cord care. One study conducted shows that applying chlorhexidine on cord in neonatal intensive care unit decreases mortality rate and decreases time of separation of cord.

Methylated spirit and chlorhexidine both have comparable efficacy and can be used in areas of non-availability of chlorhexidine and whenever chlorhexidine is not safe to use as in very preterm neonates. In Pakistan there is no population based study published on this issue this study aimed to compare the effectiveness of methylated spirit and 4% chlorohexidine from prevention of omphalitis and neonatal sepsis. This study will help to establish the use of methylated spirit in prevention of omphalitis and neonatal sepsis at low price and easy availability.

Methodology:

It was a randomized controlled trial done at the Neonatology unit, Department of Pediatrics, Shaikh Zayed Hospital, Lahore. For a period of 12 months from September 2020 to September 2021 with the hypothesis that methylated spirit is equally effective as 4% chlorhexidine in preventing omphalitis and sepsis in neonate. 300 newborns were included by probability consecutive sampling in study with 150 newborns in each group with confidence interval of 95% and margin of error 5%. Sample size was calculated using Raosoft sample size calculator.

After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk were given to mothers.

In group "A" mothers were advised the topical application of 4% chlorhexidine generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.

Neonates were followed till 10th day of life and careful examination was done for cord separation and any signs of omphalitis or sepsis. Primary outcome measure was omphalitis which was characterized by local inflamed cord. Secondary outcome measure was sepsis which was characterized by signs and symptoms such as fever, reluctance to feed, respiratory difficulty, irritability. Treatment success was labelled if there was no evidence of omphalitis or sepsis. If omphalitis or evidence of sepsis was present, the patient was treated as per hospital protocol. Data was collected according to proforma.

Statistical Analysis:

Data was entered in SPSS v.23.0 and was analyzed through it. The numeric variables like gestational age at birth and birth weight were presented as mean ± standard deviation, while the categorical variables like gender of the neonate, omphalitis and sepsis were presented as frequency (%). Both groups were compared for omphalitis and sepsis by using the chi-square (ﬡ²) test. P-value ≤ 0.05 was kept as significant. Data was stratified for gender of the neonate, gestational age at birth and birth weight to deal with the effect modifiers. Post-stratification, Chi-Square test was applied to compare both groups for omphalitis and sepsis in each strata. P-value ≤ 0.05 was kept as significant.

Being tested
Chlorhexidine Topical Cream, Methylated Spirit
Medical subject headings
Neonatal Sepsis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Chlorhexidine Topical CreamDrug

    After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk; are given to mothers.

    In group "A" 4% chlorhexidine was applied generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.

  • Methylated SpiritDrug

    After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk; are given to mothers.

    In group "A" 4% chlorhexidine was applied generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.

Study groups in NCT06002295
Study groupRoleWhat they receive
Umbilical Cord Care with Chlorhexidine (Group A)ExperimentalNot described
Receives: Drug: Chlorhexidine Topical Cream
Umbilical Cord Care with Methylated Spirit (Group B)ExperimentalNot described
Receives: Drug: Methylated Spirit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with Omphalitis

    Inflammation of the navel in newborn babies as assessed by redness and swelling of the area.

    Measured: 10 days

Secondary outcomes (1)
  1. Number of participants with Neonatal Sepsis

    It refers to an infection involving bloodstream in newborn infants less than 28 days old as assessed by following parameters: fever >38.5 °, heart rate >2SD for age, respiratory rate >2SD for age, irritability, lethargic, cyanosis, poor perfusion, feeding difficulty, urine output <0.5ml/kg/hr.

    Measured: 10 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2023
  2. Study start12 Sep 2020
  3. Primary completion22 Sep 2021
  4. Study completion19 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06002295
Sponsor's protocol ID
SZMC/IRB/Internal/MD/130/19
Status last verified
Aug 2023
First submitted
3 Aug 2023
Last updated
23 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Chlorhexidine Topical Cream and Methylated Spirit in people with Neonatal Sepsis and Omphalitis, run by Sheikh Zayed Federal Postgraduate Medical Institute at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with Omphalitis (time frame: 10 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in